Profhilo 1 x 2 ml

Profhilo

Injectable aesthetic medical device

Stabilised hyaluronic acid bioremodeling injectable (skin booster / dermal filler)

CE Marked Class III sterile injectable hyaluronic acid medical device (EU/EEA).
BDDE Free stabilised HA hybrid cooperative complexes produced with patented NAHYCO thermal technology.
Manufactured under IBSA pharmaceutical quality and medical device standards (including GMP and applicable ISO/EN standards for medical devices).

CE Marked Class III sterile injectable hyaluronic acid medical device (EU/EEA).
BDDE Free stabilised HA hybrid cooperative complexes produced with patented NAHYCO thermal technology.
Manufactured under IBSA pharmaceutical quality and medical device standards (including GMP and applicable ISO/EN standards for medical devices).

Stabilised hyaluronic acid bioremodeling injectable (skin booster / dermal filler)

Description

Profhilo 1 x 2 ml is an innovative, CE-marked injectable hyaluronic acid (HA) medical device from IBSA Derma designed for multi-level bioremodeling of skin. Each pre-filled 2 ml syringe contains 64 mg of ultrapure HA (32 mg high molecular weight + 32 mg low molecular weight) in the form of thermally stabilised hybrid cooperative complexes (HCC), produced with NAHYCO technology and without BDDE or other chemical cross-linking agents. Injected into the superficial subcutaneous layer using dedicated techniques (such as the BAP – Bio Aesthetic Points – protocol), Profhilo improves skin laxity, hydration, firmness and overall tissue quality on the face, neck, décolletage and other areas, acting more as a bio-stimulatory skin booster than a volumising filler.

Bnefits

Very high concentration of hyaluronic acid: 64 mg of HA in a 2 ml pre-filled syringe (32 mg H-HA + 32 mg L-HA), amongst the highest in its category.
BDDE-free stabilised hybrid cooperative complexes produced by NAHYCO thermal technology, reducing exposure to chemical cross-linking agents.
Bioremodeling action: stimulates fibroblasts, keratinocytes and adipocytes, improving skin quality, firmness and elasticity rather than simply filling lines.
Treats skin laxity and contour issues in the face, neck, décolletage and other body areas while providing intense, long-lasting hydration.
Homogeneous tissue diffusion and high flowability minimise risk of lumps and surface irregularities when injected correctly.
Can be used alone or in combination with other aesthetic treatments (e.g. fillers, toxins, energy-based devices) as part of a comprehensive rejuvenation plan.
Clinically studied safety and tolerability profile when administered by trained healthcare professionals following the IFU.
Convenient ready-to-use, sterile, pre-filled 2 ml syringe presentation with supplied needles and traceability labels.

Indications

Tissue remodelling and improvement in skin laxity of the face, neck and décolletage.
Contours redefinition and laxity remodelling of the malar-zygomatic and sub-malar areas of the face.
Improvement of skin quality (tone, elasticity, hydration and radiance) in areas showing signs of photo- and chrono-ageing.

Multiple distributors

PROFHILO BODY

Aesthetic Injectables

£162.00
£240.00 GBP
8 more

Aestheticsrxpharma

Profhilo Face Lift Treatment (PROFHILO H+L 1 x 2 ml)

Aesthetic Injectables

From £68.95
-1 more

Multiple distributors

Profhilo H+L (1 x 2 ml)

Aesthetic Injectables

£75.00 GBP
£83.99
7 more

Multiple distributors

PROFHILO HAENKENIUM CREAM 50ml

Cosmetics

£34.00
EUR 39.00
0 more

Multiple distributors

PROFHILO STRUCTURA IBSA (1 x 2 ml)

Aesthetic Injectables

£105.00
£115.00
7 more

Usage

Profhilo must only be administered by doctors or suitably trained and authorised healthcare professionals familiar with injectable HA medical devices and facial anatomy.
Before use, verify that the packaging and blister are intact and that the product is within its expiry date; do not use if packaging is damaged or opened.
Attach one of the supplied sterile needles securely to the syringe luer-lock, taking care not to touch the needle tip or syringe opening; expel any air bubble if necessary.
Inject Profhilo using strict aseptic technique, at room temperature, into the superficial subcutaneous / deep dermal layer as recommended in the IFU.
For global treatment of the malar and sub-malar facial areas, the manufacturer recommends the BAP (Bio Aesthetic Points) technique: typically 5 injection points per side of the face with 0.2 ml per bolus in the superficial subcutaneous plane, for a total of 2 ml per session.
Standard face protocol: 2 treatment sessions of 2 ml each, usually 4 weeks (1 month) apart; additional maintenance sessions can be performed according to clinical judgement, typically every 6–9 months depending on patient response.
Similar BAP-based schemes or adapted injection patterns can be used for the neck and other areas, following official Profhilo training, current IFU and local regulatory guidance.
Do not inject intravascularly, intramuscularly, into tendons, in or near mammary tissue, or into areas with active inflammation, infection or compromised skin.
After injection, lightly massage the treated areas if required to assist even distribution; avoid aggressive manipulation of the product.
Advise patients to avoid intense heat or cold exposure, vigorous exercise, saunas/steam rooms and sunbeds, and to minimise UV exposure for several days after treatment; recommend use of high-SPF sunscreen on exposed treated areas.
Single use only: once opened and used, any residual product must be discarded appropriately; do not resterilise and do not reuse on another patient.

Consentz Hub

Profhilo 1 x 2 ml

Description

Bnefits